Samsara Bio Capital, LLC Eliem Therapeutics, Inc. Transaction History
Samsara Bio Capital, LLC
- $173 Million
- Q3 2024
A detailed history of Samsara Bio Capital, LLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 2,609,114 shares of ELYM stock, worth $10.7 Million. This represents 7.7% of its overall portfolio holdings.
Number of Shares
2,609,114
Previous 3,261,393
20.0%
Holding current value
$10.7 Million
Previous $23.2 Million
42.73%
% of portfolio
7.7%
Previous 11.93%
Shares
2 transactions
Others Institutions Holding ELYM
# of Institutions
69Shares Held
53.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.23% of portfolio
-
Janus Henderson Group PLC London, X03.61MShares$14.8 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA2.6MShares$10.7 Million0.7% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.17MShares$8.92 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$6.27 Million0.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...